comparemela.com

Latest Breaking News On - Particle works - Page 3 : comparemela.com

Optimising mRNA-LNP Formulation with Automated Microfluidics

Particle Works is revolutionising the field of nanomedicine through the development of innovative automated microfluidic systems that have the potential to enhance the efficiency of the nanotherapeutic drug development pipeline. Click to read more.

The power of microfluidics to enhance particle performance

The COVID-19 pandemic brought lipid nanoparticles (LNPs) to prominence, with multiple pharmaceutical manufacturers – including Moderna and Pfizer-BioNTech – rapidly developing mRNA-LNP vaccines that were administered globally. The success of these vaccines has firmly established the potential of this technology to help treat a broad scope of diseases and illnesses, especially using gene therapy approaches, where LNPs are already demonstrating promise as non-viral delivery vectors. How

Particle Works: Nanoparticle synthesis platforms for drug delivery

In this product brochure, Particle Works presents its nanoparticle synthesis platforms for drug delivery.

Automated Library Synthesis (ALiS) System

In this product brochure, Particle Works presents the Automated Library Synthesis (ALiS) System.

Particle Works launches ALiS – an automated and high-throughput platform for LNP formulation screening

Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System. This innovative platform enables automation and high-throughput screening of lipid nanoparticle (LNP) formulations and mRNA candidates in early-stage drug development.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.